TARGETING OF G-CSF IN COMBINATION WITH STANDARD THERAPY FOR ADVANCED BREAST CANCER

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1080560

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Nearly all deaths caused by breast cancer are due to the spread of the cancer to other tissues such as lung and bone, ultimately leading to organ failure and death. The process of spread of cancer cells is not well understood, but it is becoming clear that cells of the immune system are key regulators of the spread of breast cancer. It is the aim of this project to target two types of immune cells, macrophages and neutrophils, seeking therapies that prevent the growth of secondary cancers.

Funded Activity Details

Start Date: 01-01-2015

End Date: 01-01-2017

Funding Scheme: Project Grants

Funding Amount: $583,166.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cancer Cell Biology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

breast cancer metastases | cancer therapy | inflammation | macrophages | neutrophils

Related Links